Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04566809
Other study ID # 3879A
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date October 21, 2017

Study information

Verified date September 2020
Source Azienda Ospedaliero, Universitaria Pisana
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

16 persons affected by Cervical-SCI were recruited for the study and randomly assigned to the Control Group (CG) or to the Experimental Group (EG). Persons of the CG (n = 8) executed 20 sessions of FES for the rehabilitation of hand functions (grasp or pinch), participants of the EG (n = 8) performed 20 sessions of FES and CBA in addition. The primary assessment was a modified version of Bimanual Activity Test (10 tasks); also, SCIM-II and measurement of grasping strength only in participants submitted to grasp rehabilitation were evaluated.


Description:

Each participant followed twenty sessions of hand rehabilitation, three times per week. Each treatment, for both CG and EG, lasted about forty minutes.

The FES devices chosen for this research stimulated "grasp" or "pinch" function: the NESS H200 (NESS Ltd., Ra'anana, Israel) was used if patient needed to improve the grasp functions, otherwise the Microstim (Microstim, Medel, Hamburg, Germany) was used to increase pinch functions. In order to provide FES, the five electrodes of NESS H200 were first humidified with warm water and then inserted in the right size place of the rigid splint worn by the patient, while Microstim was used with four standard electrodes, two for each muscle treated. In both case the stimulation was triggered by the therapist clicking a button (Table 1).

The participants of CG received only FES to improve their manipulating skills without the interaction with objects, but only with the muscle contraction induced by the devices.

The participants of EG executed FES and CBA treatment which means that during the stimulation they manipulated different tools. In particular, for the first ten sessions the participants were invited to manipulate specific objects: squares, rectangles and pyramids of different sizes; touch on plastic test tubes coated with materials of different consistency; these two exercises were performed both with open and closed eyes. Finally, for the last ten sessions the participants were asked to execute specific tasks, depending on person's life before the lesion.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date October 21, 2017
Est. primary completion date October 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- C-SCI with neurological level between C2-T1;

- reduced ability of hand functions;

- excitable muscles and FES tolerability.

Exclusion Criteria:

- any trauma or surgery to the target hand or upper limb within the last 12 months,

- amputation of any digits on the target hand,

- severe spasticity in the target hand or upper limb preventing use of the instruments,

- experienced autonomic dysreflexia or hypotension in response to FES,

- any contraindication to FES such as: cardiac pacemaker, epilepsy, forearm fracture, pregnancy, skin lesions, cancer or tumor, intracranial metal implants

Study Design


Related Conditions & MeSH terms


Intervention

Other:
FES+CBA
The experimental treatment was formerly composed by 20 sessions of FES for the hand in combination with a structured cognitive therapy
FES
The control treatment was formerly composed by 20 sessions of FES for the hand

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Azienda Ospedaliero, Universitaria Pisana

Outcome

Type Measure Description Time frame Safety issue
Primary Performance test: Bimanual Ability Test (BAT) 10 items evaluated, each one from 0 to 60 seconds. Less time needed means better skills 2 years
Secondary Spinal Cord Independence Measure (SCIM) The score varies from 0 to 100. Higher the score, patient more independent in its daily life 2 years
Secondary Grasping Strength (GS) Grasping Strength evaluated with a dynamometer (from 1 to 90 kg) more kg means more strength 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT06272279 - Neuromodulation With Spinal Stimulation Methods N/A
Recruiting NCT05638191 - Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Completed NCT04727866 - Brain Plus Spinal Stimulation for Cervical SCI N/A
Recruiting NCT05863754 - Grasp-Release Assessment of a Networked Neuroprosthesis Device N/A
Recruiting NCT02329652 - Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury N/A
No longer available NCT03925649 - Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI